(Press-News.org) Many times, cancer patients respond very well to chemotherapy initially only to have their disease return, sometimes years later. Now researchers reporting in the October 29th issue of the journal Cell, a Cell Press publication, have new insight into the factors that allow some lingering tumor cells to resist treatment and to seed that kind of resurgence.
Contrary to expectations, it appears that the answer doesn't necessarily lie in the cancerous cells themselves. The evidence based on studies of mice with lymphoma shows that cues coming from healthy cells in response to the stress of chemotherapy can protect their cancerous neighbors, allowing them to persist in select refuge sites.
"It's a surprising finding, but it's consistent with organ homeostasis," said Michael Hemann of Massachusetts Institute of Technology. For an organ to maintain itself, it has to respond to stressful conditions, he explained. "In this case, the stress response is to chemo. The chemotherapy kills tumor cells while it elicits stress responses that protect a subset of tumor cells in select locations from drug action."
That stress signal, a molecule called IL-6, allows cancer cells to persist in the thymus. They have evidence that those surviving cells are relevant to disease progression, as removal of thymus tissue prolonged the animals' tumor-free survival.
The researchers further showed that human liver cancer cells release IL-6 as well when treated with the chemotherapeutic agent doxorubicin. When they combined chemotherapy with a treatment that blocks IL-6 signaling, cancer cells were more likely to die.
If the findings in mice and human cells prove relevant in human cancer, they suggest that treatments designed to work against IL-6 might be combined with chemotherapy to reduce the chance that a cancer will recur. "The approach to cancer is usually single agents," Hemann said. "Our data suggest that a combination of DNA damaging chemotherapy or radiation plus treatments designed to block pro-survival pathways would be the most potent therapy."
Anti-IL-6 treatments are already in development for patients with arthritis, Hemann said, as IL-6 is perhaps best known for its role in inflammation.
The results come at an important time. "While significant progress has been made in the application of chemotherapy in the past 40 years, most chemotherapeutic regimens ultimately fail to cure patients," the researchers wrote. "Even tumors that show dramatic initial responses to therapy frequently relapse as chemoresistant malignancies."
In the past, most studies of resistance to chemotherapy had focused on changes within the cancer cells themselves. The cells were thought to pump drugs out faster, to activate enzymes that detoxify the chemotherapeutic agent or to lose the activity of genes involved in cell death.
But recent data began to suggest that there was another way; that resistance to chemo could arise from external factors, such as immune signaling molecules (cytokines) or growth factors. The new study adds to that evidence and is one of very few to consider the role of the tumor microenvironment in chemotherapeutic outcome, the researchers say. In other words, it's all about location.
We show that resistance to chemotherapy "relates to where the tumor is. There are some locations that are inherently protective," Hemann said.
He said he expects this survival mechanism may play a role in other forms of cancer. He notes that IL-6 is present in many microenvironments in the body. Earlier studies have also shown blood levels of IL-6 to rise in those with many types of cancer. Those high IL-6 levels have also been linked to poor survival and accelerated disease progression in a variety of cancers, including lymphomas.
Hemann said the findings show how important basic biology can be to developing new and better combination therapies to fight cancer. His team plans to conduct pre-clinical studies to see whether chemotherapy plus anti-IL-6 therapies can improve outcomes in animals with lymphoma and hepatocellular carcinoma.
###
The researchers include Luke A. Gilbert and Michael T. Hemann, of The Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA.
In response to chemo, healthy cells shield cancer cells
2010-10-29
ELSE PRESS RELEASES FROM THIS DATE:
Low birth weight may lead to poor growth rate in children with kidney disease
2010-10-29
The lower the birth weight, the greater the chance of poor growth rate in children with chronic kidney disease (CKD), according to a new study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
In the general population, low birth weight is not an important cause of poor growth and short stature. To determine whether low birth weight is a risk factor for poor growth in children with CKD, Larry Greenbaum, MD, PhD (Emory University and Children's Healthcare of Atlanta, Atlanta, GA) and his colleagues analyzed results from ...
Caltech/JPL experiments improve accuracy of ozone predictions in air-quality models
2010-10-29
PASADENA, Calif.—A team of scientists led by researchers from the California Institute of Technology (Caltech) and NASA's Jet Propulsion Laboratory (JPL) have fully characterized a key chemical reaction that affects the formation of pollutants in smoggy air. The findings suggest that in the most polluted parts of Los Angeles—and on the most polluted days in those areas—current models are underestimating ozone levels, by between 5 to 10 percent.
The results—published in this week's issue of the journal Science—are likely to have "a small but significant impact on the predictions ...
Genetic variants may affect the risk of breast cancer in women with BRCA2 mutations
2010-10-29
NEW YORK, October 28, 2010 – An international study led by researchers at Memorial Sloan-Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer. The study was published today online in the open-access journal PLoS Genetics.
The findings of the study suggest that genetic variants on chromosomes 10 and 20 may modify risk for breast cancer among women with a BRCA2 mutation.
Researchers analyzed DNA samples from 6,272 women with BRCA2 mutations in a two-stage genome-wide ...
Protein preserves delicate balance between immune response and host
2010-10-29
White blood cells called neutrophils are part of the body's first line of defense against bacterial infection. Neutrophils are recruited from the bloodstream to infected tissues where they release powerful chemicals that kill bacteria and amplify the immune response. These cells function as first responders at the scene of infection and often have a short life span. As a result, new neutrophils are produced continuously from stem cells in the bone marrow. Previous research has suggested that regulation of neutrophil production is a complex and carefully controlled process.
"We ...
Uncovering the cause of a common form of muscular dystrophy
2010-10-29
SEATTLE – An international team of researchers led by an investigator from Fred Hutchinson Cancer Research Center has made a second critical advance in determining the cause of a common form of muscular dystrophy known as facioscapulohumeral dystrophy, or FSHD.
In August 2010 the group published a landmark study that established a new and unifying model for the cause of FSHD. The current work, published Oct. 28 in PLoS Genetics, shows that the disease is caused by the inefficient suppression of a gene that is normally expressed only in early development. The work will ...
Getting a grip on CO2 capture
2010-10-29
The ability to keep CO2 out of the atmosphere to help prevent climate change is a global issue. The challenge is to use materials that can capture the CO2 and easily release it for permanent storage. Researchers at the University of Calgary and University of Ottawa have provided deeper insights to CO2 capture by "seeing" the exact sites where CO2 is held in a capture material. Their discovery, published in prestigious journal Science, will allow scientists to design better materials to capture more CO2.
The findings can be likened to learning about a better fit between ...
Olive oil protects liver
2010-10-29
Extra-virgin olive oil can protect the liver from oxidative stress. Researchers writing in BioMed Central's open access journal Nutrition and Metabolism exposed rats to a moderately toxic herbicide known to deplete antioxidants and cause oxidative stress, finding that those rats fed on a diet containing the olive oil were partially protected from the resulting liver damage.
Mohamed Hammami from the University of Monastir, Tunisia and King Saud University, Riyadh, Saudi Arabia, worked with a team of researchers to carry out the experiments in a group of 80 rats. He said, ...
Not putting the clocks back this weekend will improve health, says expert
2010-10-29
Mayer Hillman, Senior Fellow Emeritus at the Policy Studies Institute, argues that the effect of doing so would be to increase the number of 'accessible' daylight hours and thus encourage more outdoor activity throughout the year.
A major public health problem contributing to the incidence of chronic illnesses in the UK is caused by lack of exercise, writes Hillman. Adults are recommended to engage in at least 30 minutes of moderate or vigorous activity daily and children at least one hour. However, surveys have revealed a trend towards declining fitness and it has been ...
Study identifies 5 risk factors for late-stage head and neck cancer
2010-10-29
DETROIT – Developing a molecular fingerprint for head and neck cancer tumors could help improve diagnosis and treatment for this deadly and often-times disfiguring form of cancer, according to researchers at Henry Ford Hospital in Detroit.
Their new study has taken the first step toward doing that by identifying five risk factors for late-stage head and neck cancer – two genes, tumor grade, and vascular invasion and location of the tumor.
Race, however, was not an independent predictor for late-stage disease, contrary to other research findings. In fact, 88 percent ...
Fingers detect typos even when conscious brain doesn't
2010-10-29
Expert typists are able to zoom across the keyboard without ever thinking about which fingers are pressing the keys. New research from Vanderbilt University reveals that this skill is managed by an autopilot, one that is able to catch errors that can fool our conscious brain.
The research was published in the Oct. 29 issue of Science.
"We all know we do some things on autopilot, from walking to doing familiar tasks like making coffee and, in this study, typing. What we don't know as scientists is how people are able to control their autopilots," Gordon Logan, Centennial ...